{"ticker": {"uuid": "76da2cf7-50cc-4dc4-b51d-157448b7cb97", "symbol": "BRM", "name": "Bristol-Myers Squibb Company", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Bristol-Myers Squibb Company stock (US0897961004): options activity spikes as new cancer trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOLU85dFhwcUxkT0lSZVJjRlRvYl9LczFxRzVNYlN6RGdIVjM5MWhwdDREVUhjTTk5NXJEelpaeWlWbTh1bFo1OVhOMXJCTm5hUXpBQXN1MEU0NlF6SGFGYWE5RmRDTWR0VnctNE5PQ2UxYmpaaXYzWXdRenlNNHVjcDdWMW1UMnZTbnozZTRkZlB5d01lVXRCaEF0UzgwR1FnQWNHUTNJRFpyemFyVXBuQ180QkFGQlN1VW44cDlrS0ZJLUxSY0RjY1FB?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Company stock (US0897961004): EU label expansion for Opdivo follows solid Q1 ea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQY09HeWs4OFEwdy1oZ0d6N19LeXpOZjdBNGRlekxtS0gwdzA5cFBfaGdtbC1TakxTUkQ1Y0JhelVGTlN6U2NVenJaUjBxM3NxbjFoSGdseV8wUnhzc01Vc2ItcHQ3aGs1cW9zZUdPck43NEw3WVVScnZCSC1jcnZ2bjRuMkw4QWVyWGVlZllqMlQ2djMzT1E4T3dYSHJtcUtzT3NlQVVKS2VWeTF1a0VIQV9YOG1UUnpjR040TzNrRC1rd2VXNkFvVw?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPNXdveHZjcWZUX2psWUJ0ZmdTdmxscGZaOHhfZTRmc0ZSRVFXeU1raHhpbl9LNGQ3UlQ3MjhjSVZMRXUxLUhBMHN4Wkk5YXVUX1h5Y2FrSm5nOENaVV9RVE5BcGJWREs2WEliaXNsTXBzYUtDOWE4LXZGOFZvdmVKWnk4dEh4blkzNG5sMU5DZVN1cGZBa25JdWhaTmxwRERQS202cFRWdDNUM0pCbVRnWjBuYjdPMjB4cDVncjQ3M3hPUWdZSzRnRzRzYTEwb2F2SU45NTZWUkl0dw?oc=5", "source_name": "StockStory", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb stock (US1101221083): steady NYSE pricing ahead of next catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPd0NiX0ppZzAyWE9ITmlEMmstUVUtVkpPcnVuWW45SHQxdFhrd1R4Vm5QVElyQXJrYUZUX1otcnhVR2R3alltbDV0TE00RzlkWGo5N1NzZlBaWThZNkVuSUxiYmJCenljYTVCS2U4N3pHeVlJQkV1OW1Wb2dJY205b3JfNThINHEtbFZsUUR3cnR3VTgxUVpmeVFqeVB6bmh6Q3pwUGxUV09hNTdmcmNWRTNzcjJDRjR6NjdISVhOYnA5ODVUV3c?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Company stock (US0897961004): Shares ease ahead of Goldman Sachs healthcare con", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPejBEMEpjTTU3VkZhOEdpLVdJbXZaenZTNW5UTzBhMDZ2WUdFaS1EcE1wSnBub2I4VUx4c2tLaE83OEdTaDRPdTlzTU9uYkZ2T3czVi0zOWJYUEdGa3VQbHNvWFBMQ3BPRi1xSHFGaGhjaHNuVW5ZWklVTnR2aUZXcmFoaENLR0UwXzJnS1VQNWl5Qy11SW83ZmVXMHpuRmJxQXYzX2xwUTNfd2hiZFFKZThnMzJGa0VNck5mQXEwRTlscmY3UHc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNVHR1WjR1TktDVlBjMXhNQUdGa2VzSmVUQnZST19vVTVqb3NWRVlQVWRmUHdVVkY4alFTRzBmRFpkOUl5eWpPdUV2dlQ3clJlRm1PckhNVDBSdDNlVW1PbzJyZTMxcktWUXhVMXhwTlFCU0FKTHdLVXNDbEx1VklNSGxWRXhoV2VpeDZvRGFGSHNLU1gzVEpiUjFUSF90ZTFEWmhBaVdxcklHMXJuZWJPVjZkUmpaZkktWVVVVURSUkxDMXJUT3BUSEpZcXZrSDBUemcwVk9OdW5pcEh3QVRJ?oc=5", "source_name": "Barchart.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Made Its Pipeline Case at BofA. Now Comes the Proof.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ0RDUllpczhkczI2MUptb2tNOEFfY0J1eU1PR0dVbTZBdDZJeWdpMnlUUjQxU0E3OUlzS3pUQXYzZ3FOYlZHQjJaOXliVzN3NG9odmhlNzdidlE2Wm1QbDBZS0xtQ3R2TkdCSzBMMkpwYWxyODk1NWY0Y0l4c084OVdkNElfOThqV21JakRSRVZPNjhVMFJaamV6dHAwUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOT1ctTlB6WXRnTDBGRUxzWDFJTHJjbHpUS1lKVnJpbGNuMF8zamlKaHRiUnNsZENqTmNySlNmcFRIVEFSZHYtTDJ3MGtQMnNpSWo2WHNLdFNxaXdEUWpsbGxRVjhReHpyaXYxcVppU2FuSTBVSUFCZjVrVTBzbzhRbWtRM2FJWmhuMVhkaGMzWEhxWXcwMk5VWXRIMFpFQlRvbTlxNlpn0gGrAUFVX3lxTE1paFRIb0FJME9Ib2xIQV95WjQ2ZWVvNTBuR0s2aDFwaWx2OU1yRkF2NTZBU0JqQ1JvZW85UDRla2toVEltTlJ2NjdmeXdVR0ZiWmo2ZVhyOG1sQkVrd1p2RUd1WUdmQ3NOdDVzbUM1c3Z1RTkzdG1hX21vUWxidHpoNkxwMk00RlZwTU5kWDdFZGtzaGJ4Nk5xc1VXd3VoX3hwal9GZVdsYUlIMA?oc=5", "source_name": "CNBC", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPeHd1U3dNcXhRVEJGUm5pNGQ0NHpxTFNQQ0JFdjlQVTFvdXlXZmZjcXMwVV9hSmZOaUJ2YTVndGdpSHN6a0NHUGFvaE8yX0JkQ2Rlc1dtb19vSE94WklUR0FkRXVnNVhkV3E3MGgyREh5VmhpU25ZRWg5TndyekNEQ3NDYkJ3YzF2cFdHRFM3eU84VTA3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: A Defensive Dividend Stock for Volatile Markets - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQc1NRdGRCQ0NCLW1qQ3Z1QTVJUERiTkNUenktRmRiaHkzUVhrSFVtcFlMV243N3lheEpOYVRmYkJJWFdVMzRwU1JkX3hQNmg0ek9TSzBYUklXUFAwM0VDbXFYcFBZRVRIcXhOOXBlT0xDVXVVcENxNGprTlBkNG03djQ4RlNXOUthNkdYWlFGTWhTdmJKUmJWUXhOWk1fOVplZ2owOXltaWk5d2p3UVE?oc=5", "source_name": "IndexBox", "published_at": "2026-03-21T07:00:00+00:00", "published_display": "21 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPcTk0MGNHZWRKTTMtQTVRczFLYV9XeU9HQXB1Qm02czlVdHgyOFktSy1LV0NFRjQ0ZWliOTgyaEZKMmN6b0pXYU5qREl4X3BBWTVYYVJzOG5CMWRWc294dW9semc2RFlibWhKdF84di1wYWVQYk9Ra3ZxcnNQaGYtVnl0Q3Ftc19kdF9BOHlUeE9GVWFwQTM3Sk9zY1JuTldybV9sRzI1S2M5M2RL?oc=5", "source_name": "Investopedia", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Bristol-Myers Squibb Company stock (US0897961004): options activity spikes as new cancer trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOLU85dFhwcUxkT0lSZVJjRlRvYl9LczFxRzVNYlN6RGdIVjM5MWhwdDREVUhjTTk5NXJEelpaeWlWbTh1bFo1OVhOMXJCTm5hUXpBQXN1MEU0NlF6SGFGYWE5RmRDTWR0VnctNE5PQ2UxYmpaaXYzWXdRenlNNHVjcDdWMW1UMnZTbnozZTRkZlB5d01lVXRCaEF0UzgwR1FnQWNHUTNJRFpyemFyVXBuQ180QkFGQlN1VW44cDlrS0ZJLUxSY0RjY1FB?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Company stock (US0897961004): EU label expansion for Opdivo follows solid Q1 ea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQY09HeWs4OFEwdy1oZ0d6N19LeXpOZjdBNGRlekxtS0gwdzA5cFBfaGdtbC1TakxTUkQ1Y0JhelVGTlN6U2NVenJaUjBxM3NxbjFoSGdseV8wUnhzc01Vc2ItcHQ3aGs1cW9zZUdPck43NEw3WVVScnZCSC1jcnZ2bjRuMkw4QWVyWGVlZllqMlQ2djMzT1E4T3dYSHJtcUtzT3NlQVVKS2VWeTF1a0VIQV9YOG1UUnpjR040TzNrRC1rd2VXNkFvVw?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPNXdveHZjcWZUX2psWUJ0ZmdTdmxscGZaOHhfZTRmc0ZSRVFXeU1raHhpbl9LNGQ3UlQ3MjhjSVZMRXUxLUhBMHN4Wkk5YXVUX1h5Y2FrSm5nOENaVV9RVE5BcGJWREs2WEliaXNsTXBzYUtDOWE4LXZGOFZvdmVKWnk4dEh4blkzNG5sMU5DZVN1cGZBa25JdWhaTmxwRERQS202cFRWdDNUM0pCbVRnWjBuYjdPMjB4cDVncjQ3M3hPUWdZSzRnRzRzYTEwb2F2SU45NTZWUkl0dw?oc=5", "source_name": "StockStory", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb stock (US1101221083): steady NYSE pricing ahead of next catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPd0NiX0ppZzAyWE9ITmlEMmstUVUtVkpPcnVuWW45SHQxdFhrd1R4Vm5QVElyQXJrYUZUX1otcnhVR2R3alltbDV0TE00RzlkWGo5N1NzZlBaWThZNkVuSUxiYmJCenljYTVCS2U4N3pHeVlJQkV1OW1Wb2dJY205b3JfNThINHEtbFZsUUR3cnR3VTgxUVpmeVFqeVB6bmh6Q3pwUGxUV09hNTdmcmNWRTNzcjJDRjR6NjdISVhOYnA5ODVUV3c?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Company stock (US0897961004): Shares ease ahead of Goldman Sachs healthcare con", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPejBEMEpjTTU3VkZhOEdpLVdJbXZaenZTNW5UTzBhMDZ2WUdFaS1EcE1wSnBub2I4VUx4c2tLaE83OEdTaDRPdTlzTU9uYkZ2T3czVi0zOWJYUEdGa3VQbHNvWFBMQ3BPRi1xSHFGaGhjaHNuVW5ZWklVTnR2aUZXcmFoaENLR0UwXzJnS1VQNWl5Qy11SW83ZmVXMHpuRmJxQXYzX2xwUTNfd2hiZFFKZThnMzJGa0VNck5mQXEwRTlscmY3UHc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNVHR1WjR1TktDVlBjMXhNQUdGa2VzSmVUQnZST19vVTVqb3NWRVlQVWRmUHdVVkY4alFTRzBmRFpkOUl5eWpPdUV2dlQ3clJlRm1PckhNVDBSdDNlVW1PbzJyZTMxcktWUXhVMXhwTlFCU0FKTHdLVXNDbEx1VklNSGxWRXhoV2VpeDZvRGFGSHNLU1gzVEpiUjFUSF90ZTFEWmhBaVdxcklHMXJuZWJPVjZkUmpaZkktWVVVVURSUkxDMXJUT3BUSEpZcXZrSDBUemcwVk9OdW5pcEh3QVRJ?oc=5", "source_name": "Barchart.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Made Its Pipeline Case at BofA. Now Comes the Proof.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ0RDUllpczhkczI2MUptb2tNOEFfY0J1eU1PR0dVbTZBdDZJeWdpMnlUUjQxU0E3OUlzS3pUQXYzZ3FOYlZHQjJaOXliVzN3NG9odmhlNzdidlE2Wm1QbDBZS0xtQ3R2TkdCSzBMMkpwYWxyODk1NWY0Y0l4c084OVdkNElfOThqV21JakRSRVZPNjhVMFJaamV6dHAwUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOT1ctTlB6WXRnTDBGRUxzWDFJTHJjbHpUS1lKVnJpbGNuMF8zamlKaHRiUnNsZENqTmNySlNmcFRIVEFSZHYtTDJ3MGtQMnNpSWo2WHNLdFNxaXdEUWpsbGxRVjhReHpyaXYxcVppU2FuSTBVSUFCZjVrVTBzbzhRbWtRM2FJWmhuMVhkaGMzWEhxWXcwMk5VWXRIMFpFQlRvbTlxNlpn0gGrAUFVX3lxTE1paFRIb0FJME9Ib2xIQV95WjQ2ZWVvNTBuR0s2aDFwaWx2OU1yRkF2NTZBU0JqQ1JvZW85UDRla2toVEltTlJ2NjdmeXdVR0ZiWmo2ZVhyOG1sQkVrd1p2RUd1WUdmQ3NOdDVzbUM1c3Z1RTkzdG1hX21vUWxidHpoNkxwMk00RlZwTU5kWDdFZGtzaGJ4Nk5xc1VXd3VoX3hwal9GZVdsYUlIMA?oc=5", "source_name": "CNBC", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPeHd1U3dNcXhRVEJGUm5pNGQ0NHpxTFNQQ0JFdjlQVTFvdXlXZmZjcXMwVV9hSmZOaUJ2YTVndGdpSHN6a0NHUGFvaE8yX0JkQ2Rlc1dtb19vSE94WklUR0FkRXVnNVhkV3E3MGgyREh5VmhpU25ZRWg5TndyekNEQ3NDYkJ3YzF2cFdHRFM3eU84VTA3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: A Defensive Dividend Stock for Volatile Markets - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQc1NRdGRCQ0NCLW1qQ3Z1QTVJUERiTkNUenktRmRiaHkzUVhrSFVtcFlMV243N3lheEpOYVRmYkJJWFdVMzRwU1JkX3hQNmg0ek9TSzBYUklXUFAwM0VDbXFYcFBZRVRIcXhOOXBlT0xDVXVVcENxNGprTlBkNG03djQ4RlNXOUthNkdYWlFGTWhTdmJKUmJWUXhOWk1fOVplZ2owOXltaWk5d2p3UVE?oc=5", "source_name": "IndexBox", "published_at": "2026-03-21T07:00:00+00:00", "published_display": "21 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPcTk0MGNHZWRKTTMtQTVRczFLYV9XeU9HQXB1Qm02czlVdHgyOFktSy1LV0NFRjQ0ZWliOTgyaEZKMmN6b0pXYU5qREl4X3BBWTVYYVJzOG5CMWRWc294dW9semc2RFlibWhKdF84di1wYWVQYk9Ra3ZxcnNQaGYtVnl0Q3Ftc19kdF9BOHlUeE9GVWFwQTM3Sk9zY1JuTldybV9sRzI1S2M5M2RL?oc=5", "source_name": "Investopedia", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 11, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 8, "score": 50, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 4.75, "count": 8}, {"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 47.89, "latest_week": "2026-06-19", "one_week_move": -2.9, "four_week_move": -6.5, "twelve_week_move": -5.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.96968, "market_dynamics_buy_signal": false, "relative_strength": 5.084023, "fair_value_gap": 9.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.2682, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.9% over one week, -6.5% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "AD HOC NEWS", "count": 4}, {"label": "StockStory", "count": 1}, {"label": "Barchart.com", "count": 1}, {"label": "TIKR.com", "count": 1}, {"label": "CNBC", "count": 1}, {"label": "Seeking Alpha", "count": 1}, {"label": "IndexBox", "count": 1}, {"label": "Investopedia", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-2.9% over one week, -6.5% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Bristol-Myers Squibb Company stock (US0897961004): options activity spikes as new cancer trial data"}], "updated_at": "2026-06-23T03:26:05.123206+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}